ACORDA THERAPEUTICS INC - COM (ACOR)

Historical Holders from Q1 2014 to Q1 2021

Type / Class: Equity / COM
Symbol: ACOR

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2021 Q1	0	$0	-$8,724,994	$0	$0		0
2020 Q4	12,679,412	$8,750,000	-$3,308,381	$52,000	$99,000	$0.6900	34
2020 Q3	19,157,623	$9,865,012	-$3,188,787	$790,000	$48,000	$0.5150	52
2020 Q2	23,978,654	$17,609,898	-$14,779,559	$2,068,000	$34,000	$0.7341	72
2020 Q1	42,765,744	$39,893,870	-$10,764,807	$2,657,000	$54,000	$0.9327	99
2019 Q4	51,782,033	$105,650,297	-$12,405,634	$522,000	$401,000	$2.04	117
2019 Q3	54,689,892	$156,984,254	-$28,662,955	$991,000	$568,000	$2.87	141
2019 Q2	58,958,882	$452,049,848	+$2,893,545	$1,094,000	$1,711,000	$7.67	156
2019 Q1	57,332,499	$761,915,485	+$45,847,536	$4,375,000	$2,282,000	$13.29	180
2018 Q4	53,507,547	$833,486,257	+$30,814,446	$13,821,000	$8,185,000	$15.58	176
2018 Q3	51,575,198	$1,013,382,877	+$32,160,944	$15,625,000	$42,253,000	$19.65	171
2018 Q2	49,562,141	$1,422,370,665	-$39,695,733	$22,822,000	$13,923,000	$28.70	177
2018 Q1	51,384,694	$1,214,918,052	+$14,836,151	$21,694,000	$8,917,000	$23.65	160
2017 Q4	50,845,800	$1,090,819,718	-$56,419,769	$11,773,000	$4,262,000	$21.45	148
2017 Q3	53,354,740	$1,261,887,801	+$58,865,169	$7,500,000	$6,194,000	$23.65	153
2017 Q2	50,883,956	$1,002,642,263	+$48,056,987	$11,951,000	$4,805,000	$19.70	148
2017 Q1	48,044,196	$1,008,840,291	+$141,673,641	$64,891,000	$17,216,000	$21.00	174
2016 Q4	47,792,819	$898,891,753	-$17,187,661	$25,281,000	$6,124,000	$18.80	173
2016 Q3	48,381,478	$1,009,877,285	+$11,049,408	$19,801,000	$9,608,000	$20.88	166
2016 Q2	47,782,628	$1,218,906,842	+$11,659,791	$17,534,000	$2,529,000	$25.50	176
2016 Q1	47,320,565	$1,251,627,011	-$44,687,693	$7,577,000	$1,032,000	$26.45	193
2015 Q4	48,054,999	$2,055,637,047	+$80,461,791	$13,497,000	$9,536,000	$42.78	186
2015 Q3	46,274,271	$1,226,586,071	+$20,181,799	$8,316,000	$1,822,000	$26.51	175
2015 Q2	45,282,166	$1,509,408,420	-$19,244,118	$2,016,000	$1,990,000	$33.33	172
2015 Q1	45,782,240	$1,523,292,063	+$40,903,345	$5,155,000	$7,212,000	$33.28	189
2014 Q4	44,286,464	$1,810,154,984	-$17,114,017	$4,875,000	$12,577,000	$40.87	179
2014 Q3	44,798,255	$1,517,940,963	+$52,167,371	$7,863,000	$12,972,000	$33.88	175
2014 Q2	43,266,802	$1,457,538,406	+$24,989,976	$4,433,000	$2,636,000	$33.71	163
2014 Q1	41,337,404	$1,566,244,601	+$69,032,630	$1,668,000	$2,317,000	$37.91	152